<DOC>
	<DOCNO>NCT00271219</DOCNO>
	<brief_summary>Children born woman abuse drug high risk bear birth defect developmental problem . Methadone drug commonly use treat opioid dependence . However , use pregnant woman cause severe withdrawal symptom newborn prenatal exposure . The purpose study evaluate effectiveness buprenorphine , another drug , versus methadone reduce withdrawal symptom child bear opioid-dependent woman .</brief_summary>
	<brief_title>RCT Comparing Methadone Buprenorphine Pregnant Women</brief_title>
	<detailed_description>Women use drug pregnancy place unborn child high risk bear addict drug . Such child may also bear birth defect may experience learn behavioral problem . Methadone , synthetic narcotic , commonly prescribe treat opioid addiction . It may optimal solution opioid-dependent pregnant woman , however , large percentage child bear woman take methadone experience severe drug withdrawal symptom birth often require medical treatment . Common opioid withdrawal symptom , describe neonatal abstinence syndrome ( NAS ) baby , include tremor , irritability , sleep problem , seizure , dehydration , fever . Buprenorphine medication approve treat opioid dependence individual pregnant approve pregnant individual . Past research show use buprenorphine pregnant woman result improve birth outcomes methadone . The purpose study evaluate effectiveness buprenorphine versus methadone reduce opioid withdrawal symptom baby bear opioid-dependent woman . This study enroll opioid-dependent pregnant woman 13 30 week pregnant follow woman child throughout pregnancy 6 week postpartum . All participant undergo initial screening last several hour . Participants randomly assign receive either methadone buprenorphine daily basis , require visit clinic day receive medication . Outcome measurement assess weekly study visit throughout pregnancy , include drug use , HIV risk behavior , medication dose adequacy safety , treatment retention , psychosocial functioning . Urine sample collect 3 time week , blood drawn throughout pregnancy safety monitoring . Outcome measurement related baby include head circumference measurement , length hospital stay , severity frequency withdrawal symptom , amount medication need control withdrawal symptom .</detailed_description>
	<mesh_term>Opioid-Related Disorders</mesh_term>
	<mesh_term>Buprenorphine</mesh_term>
	<mesh_term>Methadone</mesh_term>
	<criteria>Current opioid dependence Current opioid use , determined urine drug test Pregnant single child gestational age 6 30 week , determine sonogram Current medical condition would make study participation dangerous , determine study physician Diagnosed acute , severe psychiatric illness Current SCID IE module diagnosis benzodiazepine alcohol abuse Use alcohol benzodiazepine 30 day prior study entry , determine Addiction Severity Index Pending legal action may prohibit interfere study participation</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>41 Years</maximum_age>
	<verification_date>July 2015</verification_date>
	<keyword>opiate addiction</keyword>
	<keyword>opiate dependence</keyword>
	<keyword>substance abuse</keyword>
	<keyword>addiction</keyword>
	<keyword>substance addiction</keyword>
	<keyword>pregnancy</keyword>
	<keyword>buprenorphine</keyword>
	<keyword>methadone</keyword>
	<keyword>fetal</keyword>
	<keyword>neonatal</keyword>
	<keyword>post-partum</keyword>
</DOC>